Has Bradley Katz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,855 in general payments to Bradley Katz, MD across 546 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bradley Katz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bradley Katz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bradley Katz, MD

Interventional Pain Medicine · Montgomery, ALNPI 1891841581

Payments from drug & device makers

$11,855in general payments, 2019–2025

Across 546 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$8K
Boston Scientific$903
Collegium Pharmaceutical, Inc.$534
Scilex Pharmaceuticals Inc.$307
Nevro Corp.$257
Arbor Pharmaceuticals, Inc.$214
plus $2K from 36 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	339	$7,690
Boston Scientific	31	$903
Collegium Pharmaceutical, Inc.	31	$534
Scilex Pharmaceuticals Inc.	18	$307
Nevro Corp.	11	$257
Arbor Pharmaceuticals, Inc.	11	$214
Amgen	10	$209
AbbVie(2 entities)	12	$204
Forte Bio-pharma LLC	5	$148
Pfizer	14	$122
Teva Pharmaceuticals USA, Inc.	7	$118
Curonix LLC	1	$98
Azurity Pharmaceuticals, Inc.	4	$72
Biodelivery Sciences International, Inc.	4	$72
Supernus Pharmaceuticals, Inc.	3	$60
Eisai Inc.	3	$55
Idorsia Pharmaceuticals US Inc	3	$53
Daiichi Sankyo Inc.	3	$50
Centinel Spine, LLC	1	$46
Lilly USA, LLC	3	$44
Vertex	2	$43
Medtronic	2	$42
SPR Therapeutics, Inc	2	$40
Novartis	2	$39
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$37
Vertos Medical, Inc.	1	$34
Biohaven Pharmaceutical Holding Company Ltd.	2	$34
Assertio Therapeutics, Inc.	2	$34
Takeda Pharmaceuticals U.S.A., Inc.	2	$32
Ossur Americas, Inc.	2	$30
GRT US Holding, Inc.	2	$28
Almatica Pharma LLC	1	$26
Bioventus LLC	1	$25
Saluda Medical Americas, Inc.	1	$24
Virtus Pharmaceuticals LLC	1	$22
Novo Nordisk	1	$21
Zyla Life Sciences, Inc.	1	$20
Redhill Biopharma Inc.	1	$18
Neuronetics, Inc.	1	$14
AstraZeneca	1	$12
Kowa Pharmaceuticals America, Inc.	1	$12
Si-bone, Inc.	1	$12

How this compares

$11,855 in reported general payments places this provider in the 75th percentile of 33 interventional pain medicine providers in Alabama.

See all interventional pain medicine providers in Alabama →

Medicare billing

Part B allowed, 2024

$1,107,661

Medicare patients

985

Services billed

83,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Montgomery

Jacob VellaMontgomery$28K
David HerrickMontgomery$9K
John MarsellaMontgomery$8K
Roger KempMontgomery$74
Michael KendrickBirmingham$90K
Bradley WargoMuscle Shoals$41K
John IronsVestavia$22K
Richard WebbFoley$18K
Ryan AlmeidaBirmingham$14K
Roberto ChangHoover$13K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →